Autolus Therapeutics plc

AUTL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$221-$208-$149-$142
Dep. & Amort.$8$7$7$8
Deferred Tax-$0-$1-$0-$0
Stock-Based Comp.$15$11$12$10
Change in WC-$24$0$4$4
Other Non-Cash$15$46$13$2
Operating Cash Flow-$206-$146-$112-$118
Investing Activities
PP&E Inv.-$22-$11-$11-$9
Net Acquisitions$0$0$0$0
Inv. Purchases-$360$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$13$0$0$0
Investing Cash Flow-$395-$11-$11-$9
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$550$0$164$246
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$40-$1$60$38
Financing Cash Flow$590-$1$224$284
Forex Effect-$0$15-$28-$1
Net Chg. in Cash-$12-$142$72$157
Supplemental Information
Beg. Cash$240$383$311$154
End Cash$229$240$383$311
Free Cash Flow-$241-$157-$123-$127